|
LEPROT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.15760000368925E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6290000015573E-08 |
| Normal-vs-Stage2 |
5.402200E-02 |
| Normal-vs-Stage3 |
3.002200E-04 |
| Normal-vs-Stage4 |
8.782800E-03 |
| Stage1-vs-Stage2 |
3.306200E-01 |
| Stage1-vs-Stage3 |
8.008000E-01 |
| Stage1-vs-Stage4 |
7.035000E-01 |
| Stage2-vs-Stage3 |
5.442200E-01 |
| Stage2-vs-Stage4 |
4.135000E-01 |
| Stage3-vs-Stage4 |
6.030600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.9654000051963E-08 |
| Normal-vs-AfricanAmerican |
1.51630000000402E-07 |
| Normal-vs-Asian |
1.383140E-03 |
| Caucasian-vs-AfricanAmerican |
4.189800E-01 |
| Caucasian-vs-Asian |
6.240600E-01 |
| AfricanAmerican-vs-Asian |
8.084800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.61659973874873E-10 |
| Normal-vs-Female |
1.633730E-02 |
| Male-vs-Female |
5.759400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.82390000014988E-07 |
| Normal-vs-Extreme_Weight |
6.72899957976369E-10 |
| Normal-vs-Obese |
5.85109999999833E-05 |
| Normal-vs-Extreme_Obese |
3.162600E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.320800E-01 |
| Normal_Weight-vs-Obese |
2.591600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.336800E-01 |
| Extreme_Weight-vs-Obese |
6.201500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.510000E-01 |
| Obese-vs-Extreme_Obese |
4.574000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.168400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.58409999999809E-05 |
| Normal-vs-Age(61-80Yrs) |
2.80290002319106E-09 |
| Normal-vs-Age(81-100Yrs) |
4.37169999978337E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.951000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.640840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.884300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.820200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.370000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.435000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.21120002705544E-09 |
| Normal-VS-Type2 PRCC |
5.11049999984969E-07 |
| Normal-VS-KIRP CIMP |
7.240000E-01 |
| Normal-VS-Unclassified PRCC |
3.219200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.884800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.799500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.012100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.763830E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.723700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.552600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.40739999654471E-08 |
| Normal-vs-N1 |
8.420100E-03 |
| Normal-vs-N2 |
4.685800E-01 |
| N0-vs-N1 |
1.238580E-01 |
| N0-vs-N2 |
3.859400E-01 |
| N1-vs-N2 |
9.174800E-01 |
|
|
